House Ways and Means Committee leaders today released a white paper summarizing stakeholder recommendations for Medicare-related legislation to address the opioid crisis, which the committee plans to use to develop and advance bipartisan policies. The committee in February requested feedback on specific questions related to overprescribing, data tracking, beneficiary notification, provider education, and treatment options. “We are hopeful this legislation will touch on many of the stakeholder recommendations, including but not limited to those related to Medicare treatment options/coverage, improving data tracking/prescribing practices, and educating providers and beneficiaries about the risks of long-term opioid use,” the white paper states. AHA submitted its policy recommendations to the committee last month.

Related News Articles

Headline
The White House June 6 issued a memorandum directing the Secretary of the Department of Health and Human Services “to take appropriate action to eliminate…
Headline
The Government Accountability Office May 29 released a report recommending the Centers for Medicare & Medicaid Services target behavioral health services…
Headline
The Centers for Medicare & Medicaid Services May 21 announced it will immediately begin annual audits of all Medicare Advantage plans and work to clear a…
Headline
The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation…
Headline
Overdose deaths in the U.S. fell 26.9% last year to 80,391, according to estimates from the Centers for Disease Control and Prevention. The agency reported…
Headline
Leaders from the Centers for Medicare & Medicaid Services at the 2025 AHA Annual Membership Meeting May 5 discussed issues on the agency’s agenda in a…